查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790480

美国止血瓣膜市场规模、份额和趋势分析报告：按类型、应用、最终用途和细分市场预测，2025 年至 2033 年

U.S. Hemostasis Valve Market Size, Share & Trends Analysis Report By Type (Hemostasis Valve Y-Connectors, Double Y-Connector Hemostasis Valves), By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国止血瓣市场规模及趋势：

预计 2024 年美国止血瓣市场规模为 6,447 万美元，2025 年至 2033 年复合年增长率为 5.4%。

心血管疾病盛行率上升、监管支持力度加大、人口老化加剧以及技术持续进步等诸多关键因素推动了市场显着成长。其中一个显着的驱动因素是人们对微创手术的日益偏好，微创手术相较于传统开放性手术具有诸多优势，例如疼痛减轻、住院时间缩短、恢復速度更快以及併发症风险更低。

这种转变刺激了对支持这些手术的医疗设备的需求。止血阀在微创导管手术中发挥着至关重要的作用，它能够确保血流可控，并防止手术过程中渗漏。

空气污染日益被认为是导致心血管疾病增加的主要原因。 《2024年世界心臟报告》强调，空气污染会加剧所有主要心血管疾病（CVD）。 2019年，在与环境空气污染相关的420万例死亡中，近70%是由心血管疾病引起的，尤其是缺血性心臟疾病（190万人死亡）和中风（90万人死亡）。因此，对血管造影术和血管成形术等诊断和治疗程序的需求日益增加，而止血瓣膜在导管介入治疗期间透过调节血流，在维护患者安全方面发挥关键作用。

医疗设备的技术进步是市场成长的关键驱动力。持续的技术进步在提高止血瓣膜的性能和可靠性方面发挥关键作用。製造商不断创新，以改进瓣膜设计、材料品质以及与各种导管尺寸和介入工具的兼容性。这些改善有助于降低漏血风险，提高临床医师的易用性，并增强微创手术期间的病人安全性。例如，Merit Medical Systems 提供先进的止血瓣膜，例如 Merit AccessPLUS 和 Honor 止血瓣膜，它们具有人体工学设计、卓越的密封机制和强大的止血控制。这些技术创新体现了业界对优化手术效率和减少导管介入手术併发症的关注。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国止血瓣膜市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国止血瓣膜市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国止血阀市场：按类型估计和趋势分析

  • 美国止血阀市场：类型仪表板
  • 美国止血瓣膜市场：类型变化分析
  • 美国止血阀市场（按类型和销售）
  • 止血阀Y型接头
  • 双Y型接头止血阀
  • 单手止血阀
  • 其他的

第五章美国止血阀市场：应用评估与趋势分析

  • 美国止血阀市场：应用仪表板
  • 美国止血阀市场：应用变化分析
  • 美国止血阀市场（按应用和销售）
  • 血管造影术
  • 血管成形术
    • 2021年至2033年的市场估计与预测

第六章美国止血瓣市场：最终用途估计与趋势分析

  • 美国止血阀市场：最终用途仪表板
  • 美国止血瓣膜市场：最终用途差异分析
  • 美国止血阀市场的应用与销售情况
  • 医院
  • 门诊手术中心
  • 其他的

第七章 竞争态势

  • 主要製造商的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • Key company market share analysis, 2024
  • 公司简介
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • Merit Medical Systems
    • B. Braun
    • Terumo Corporation
    • Abbott
    • Argon Medical Devices
    • Freudenberg Medical
    • DeRoyal Industries, Inc.
    • Antmed Corporation
Product Code: GVR-4-68040-662-4

U.S. Hemostasis Valve Market Size & Trends:

The U.S. hemostasis valve market size was estimated at USD 64.47 million in 2024 and is projected to grow at a CAGR of 5.4% from 2025 to 2033.The market is experiencing significant growth due to several key factors, including the rising incidence of cardiovascular diseases, favorable regulatory support, an aging population, and ongoing technological advancements. A notable driver is the increasing preference for minimally invasive procedures, which offer advantages such as less pain, shorter hospital stays, quicker recovery, and a reduced risk of complications compared to traditional open surgeries.

This shift is fueling the demand for medical devices that support these techniques. Hemostasis valves play a critical role in minimally invasive catheter-based procedures by ensuring controlled blood flow and preventing leakage during interventions.

Air pollution is increasingly recognized as a major contributor to the rise in cardiovascular diseases. Both chronic and short-term exposures significantly raise the risk of cardiovascular emergencies and mortality in the U.S. The World Heart Report 2024 highlights that air pollution worsens all major cardiovascular diseases (CVDs). In 2019, nearly 70% of the 4.2 million deaths linked to ambient air pollution were due to cardiovascular issues, particularly ischemic heart disease (1.9 million deaths) and stroke (900,000 deaths). As a result, there is an increased need for diagnostic and therapeutic procedures such as angiography and angioplasty, where hemostasis valves play a crucial role in maintaining patient safety by regulating blood flow during catheter-based interventions.

Technological advancements in medical devices are pivotal in driving the market growth. Ongoing technological advancements are playing a key role in improving the performance and reliability of hemostasis valves. Manufacturers are continuously innovating to enhance valve design, material quality, and compatibility with a variety of catheter sizes and interventional tools. These improvements help reduce the risk of blood leakage, improve ease of use for clinicians, and enhance patient safety during minimally invasive procedures. For example, Merit Medical Systems offers advanced hemostasis valves such as the Merit AccessPLUS and Honor Hemostasis Valves, which are designed with ergonomic features, superior sealing mechanisms, and robust hemostatic control. These innovations reflect the industry's focus on optimizing procedural efficiency and reducing complications in catheter-based interventions.

U.S. Hemostasis Valve Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. hemostasis valve market report based on type, application, and end use:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Hemostasis Valve Y- Connectors
  • Double Y- Y-Connector Hemostasis Valves
  • One-Handed Hemostasis Valves
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Angiography
  • Angioplasty
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Volume price analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Hemostasis Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of coronary artery disease (CAD)
      • 3.2.1.2. Advancements in technologies
      • 3.2.1.3. Shift towards minimally invasive procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Product recalls
      • 3.2.2.2. Clinical complexity and procedural risks
  • 3.3. U.S. Hemostasis Valve Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Hemostasis Valve Market: Type Estimates & Trend Analysis

  • 4.1. U.S. Hemostasis Valve Market: Type Dashboard
  • 4.2. U.S. Hemostasis Valve Market: Type Movement Analysis
  • 4.3. U.S. Hemostasis Valve Market by Type, Revenue
  • 4.4. Hemostasis Valve Y-Connectors
    • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5. Double Y-Connector Hemostasis Valves
    • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. One-Handed Hemostasis Valves
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. U.S. Hemostasis Valve Market: Application Estimates & Trend Analysis

  • 5.1. U.S. Hemostasis Valve Market: Application Dashboard
  • 5.2. U.S. Hemostasis Valve Market: Application Movement Analysis
  • 5.3. U.S. Hemostasis Valve Market by Application, Revenue
  • 5.4. Angiography
    • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Angioplasty
    • 5.5.1. Market estimates and forecast 2021to 2033 (USD Million)

Chapter 6. U.S. Hemostasis Valve Market: End Use Estimates & Trend Analysis

  • 6.1. U.S. Hemostasis Valve Market: End Use Dashboard
  • 6.2. U.S. Hemostasis Valve Market: End Use Movement Analysis
  • 6.3. U.S. Hemostasis Valve Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Boston Scientific Corporation
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Teleflex Incorporated
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Merit Medical Systems
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. B. Braun
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Terumo Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Abbott
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Argon Medical Devices
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Freudenberg Medical
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. DeRoyal Industries, Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Antmed Corporation
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 List of secondary sources
  • Table 3 U.S. Hemostasis Valve market, by type, 2018 - 2030 (USD Million)
  • Table 4 U.S. Hemostasis Valve market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. Hemostasis Valve market, by end use, 2018 - 2030 (USD Million)
  • Table 6 Participant's overview
  • Table 7 Financial performance
  • Table 8 Key companies undergoing expansions
  • Table 9 Key companies undergoing acquisitions
  • Table 10 Key companies undergoing collaborations
  • Table 11 Key companies launching new services
  • Table 12 Key companies undergoing partnerships
  • Table 13 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. Hemostasis Valve market segmentation
  • Fig. 7 Market snapshot, 2024
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis (current & future impact)
  • Fig. 10 Market restraint relevance analysis (current & future impact)
  • Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 U.S. Hemostasis Valve market: Type Outlook Key Takeaways
  • Fig. 14 U.S. Hemostasis Valve market: Type Movement Analysis
  • Fig. 15 Hemostasis Valve Y-Connectors market, 2018 - 2030 (USD Million)
  • Fig. 16 Double Y-Connector Hemostasis Valves market, 2018 - 2030 (USD Million)
  • Fig. 17 One-Handed Hemostasis Valves market, 2018 - 2030 (USD Million)
  • Fig. 18 Others market, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Hemostasis Valve market: Application outlook key takeaways
  • Fig. 20 U.S. Hemostasis Valve market: Application movement analysis
  • Fig. 21 Angiography market, 2018 - 2030 (USD Million)
  • Fig. 22 Angioplasty market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Hemostasis Valve market: End Use outlook key takeaways
  • Fig. 24 U.S. Hemostasis Valve market: End Use movement analysis
  • Fig. 25 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 26 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 27 Others market, 2018 - 2030 (USD Million)
  • Fig. 28 Strategy framework